Literature DB >> 27870415

The importance of studying sex differences in disease: The example of multiple sclerosis.

Lisa C Golden1,2, Rhonda Voskuhl1.   

Abstract

To date, scientific research has often focused on one sex, with assumptions that study of the other sex would yield similar results. However, many diseases affect males and females differently. The sex of a patient can affect the risk for both disease susceptibility and progression. Such differences can be brought to the laboratory bench to be investigated, potentially bringing new treatments back to the clinic. This method of research, known as a "bedside to bench to bedside" approach, has been applied to studying sex differences in multiple sclerosis (MS). Females have greater susceptibly to MS, while males have worse disease progression. These two characteristics of the disease are influenced by the immune system and the nervous system, respectively. Thus, sex differences in each system must be studied. Personalized medicine has been at the forefront of research recently, and studying sex differences in disease fits with this initiative. This review will discuss the known sex differences in MS and highlight how investigating them can lead to new insights and potential treatments for both men and women.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  estrogen; experimental autoimmune encephalomyelitis; four core genotypes; sex chromosomes; testosterone

Mesh:

Year:  2017        PMID: 27870415      PMCID: PMC5825192          DOI: 10.1002/jnr.23955

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  133 in total

1.  Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.

Authors:  M Dalal; S Kim; R R Voskuhl
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

2.  17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.

Authors:  A Matejuk; K Adlard; A Zamora; M Silverman; A A Vandenbark; H Offner
Journal:  J Neurosci Res       Date:  2001-09-15       Impact factor: 4.164

3.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

Authors:  B Runmarker; O Andersen
Journal:  Brain       Date:  1993-02       Impact factor: 13.501

Review 4.  Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

Authors:  R R Voskuhl; K Palaszynski
Journal:  Neuroscientist       Date:  2001-06       Impact factor: 7.519

5.  The natural history of secondary progressive multiple sclerosis.

Authors:  Marcus Koch; Elaine Kingwell; Peter Rieckmann; Helen Tremlett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-16       Impact factor: 10.154

6.  Context-specific effects of estradiol on spatial learning and memory in the zebra finch.

Authors:  M A Rensel; L Salwiczek; J Roth; B A Schlinger
Journal:  Neurobiol Learn Mem       Date:  2012-12-17       Impact factor: 2.877

7.  Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.

Authors:  Laura Garay; Maria Claudia Gonzalez Deniselle; Lobke Gierman; Maria Meyer; Analia Lima; Paulina Roig; Alejandro F De Nicola
Journal:  Neuroimmunomodulation       Date:  2008-07-29       Impact factor: 2.492

8.  Sex differences in cytokine responses to myelin peptides in multiple sclerosis.

Authors:  Clara M Pelfrey; Anne C Cotleur; Jar-Chi Lee; Richard A Rudick
Journal:  J Neuroimmunol       Date:  2002-09       Impact factor: 3.478

9.  Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse.

Authors:  A Brown; D E McFarlin; C S Raine
Journal:  Lab Invest       Date:  1982-02       Impact factor: 5.662

10.  Estrogen receptor-β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease.

Authors:  Sienmi Du; Francisco Sandoval; Pauline Trinh; Elizabeth Umeda; Rhonda Voskuhl
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

View more
  35 in total

1.  Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease.

Authors:  Tessa Dhaeze; Catherine Lachance; Laurence Tremblay; Camille Grasmuck; Lyne Bourbonnière; Sandra Larouche; Olivia Saint-Laurent; Marc-André Lécuyer; Rose-Marie Rébillard; Stephanie Zandee; Alexandre Prat
Journal:  JCI Insight       Date:  2019-03-21

2.  Differential trajectories of neurocognitive functioning in females versus males following treatment for pediatric brain tumors.

Authors:  Jesse C Bledsoe; David Breiger; Micah Breiger; Sophia Shonka; Ralph P Ermoian; Jeffrey G Ojemann; David M Werny; Sarah E S Leary; J Russell Geyer
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

Review 3.  Four Core Genotypes and XY* mouse models: Update on impact on SABV research.

Authors:  Arthur P Arnold
Journal:  Neurosci Biobehav Rev       Date:  2020-09-24       Impact factor: 8.989

4.  Telomere Length Is Associated with Disability Progression in Multiple Sclerosis.

Authors:  Kristen M Krysko; Roland G Henry; Bruce A C Cree; Jue Lin; Stacy Caillier; Adam Santaniello; Chao Zhao; Refujia Gomez; Carolyn Bevan; Dana L Smith; William Stern; Gina Kirkish; Stephen L Hauser; Jorge R Oksenberg; Jennifer S Graves
Journal:  Ann Neurol       Date:  2019-10-02       Impact factor: 10.422

5.  Incorporating sex as a biological variable in neuroscience: what do we gain?

Authors:  Margaret M McCarthy; Catherine S Woolley; Arthur P Arnold
Journal:  Nat Rev Neurosci       Date:  2017-11-03       Impact factor: 34.870

Review 6.  Vitamin D and Genetic Susceptibility to Multiple Sclerosis.

Authors:  Concetta Scazzone; Luisa Agnello; Giulia Bivona; Bruna Lo Sasso; Marcello Ciaccio
Journal:  Biochem Genet       Date:  2020-11-07       Impact factor: 1.890

7.  The road less traveled: from genotype to phenotype in flies and humans.

Authors:  Robert R H Anholt; Trudy F C Mackay
Journal:  Mamm Genome       Date:  2017-10-20       Impact factor: 2.957

Review 8.  The promises and pitfalls of sex difference research.

Authors:  Liisa A M Galea; Elena Choleris; Arianne Y K Albert; Margaret M McCarthy; Farida Sohrabji
Journal:  Front Neuroendocrinol       Date:  2019-12-16       Impact factor: 8.606

Review 9.  Impact of sex hormones on immune function and multiple sclerosis development.

Authors:  María C Ysrraelit; Jorge Correale
Journal:  Immunology       Date:  2018-10-11       Impact factor: 7.397

Review 10.  Sexual dimorphism in immunometabolism and autoimmunity: Impact on personalized medicine.

Authors:  Robbie S J Manuel; Yun Liang
Journal:  Autoimmun Rev       Date:  2021-02-17       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.